Skip to content

Cornea & Keratoconus

FDA-Approved Corneal Cross-Linking

In 2016 the FDA approved corneal cross-linking for progressive keratoconus and for corneal ectasia after refractive surgery, using a specific riboflavin formulation and ultraviolet system with the epithelium removed. The approval followed randomized trials showing that treated corneas stopped steepening while untreated ones continued. It is the only cross-linking protocol with FDA approval, it is what most insurers cover, and it is the protocol Dr. Youssefzadeh discusses with patients at Global LASIK & Cataract Institute.

Medically reviewed by Dr. Bavand Youssefzadeh, DO

Approved
2016, for progressive keratoconus and post-surgical ectasia
Protocol
Epithelium-off, riboflavin, UVA
Evidence
Randomized controlled trials
Coverage
Often medical insurance; coverage checked first

What was approved

The FDA approval covers a defined system: specific riboflavin ophthalmic solutions, with and without dextran, used with a specific ultraviolet A light source, in a protocol in which the corneal epithelium is removed before the riboflavin is applied. The indications are progressive keratoconus and corneal ectasia following refractive surgery, in patients 14 and older. The approval was based on three randomized, controlled clinical trials in the United States in which treated eyes showed a flattening of the steepest corneal curvature over a year while untreated eyes continued to steepen.

Why the approval matters to patients

  • Evidence: the approved protocol is the one with controlled trial data behind it, and with long-term follow-up in Europe, where it originated
  • Consistency: the drug, the light dose and the technique are standardized, so results are predictable
  • Coverage: medical insurers often cover the FDA approved procedure for progressive keratoconus; unapproved variants are usually not covered
  • Safety oversight: adverse events are reported and tracked as for any approved treatment

Approved versus other protocols

Several variations exist: epithelium-on techniques that leave the surface intact for a gentler recovery, accelerated protocols with higher intensity and shorter exposure, and combinations with laser reshaping. Some are used under research protocols or outside the United States, and some show promise. They do not carry FDA approval, their long term data are thinner, and insurers generally do not cover them. The approved epithelium-off protocol is the one with established effectiveness, and the cornea specialist will discuss alternatives frankly if you ask.

Eligibility under the approval

Progressive keratoconus, demonstrated by change on tomography, or ectasia after LASIK or PRK; age 14 or older; a cornea thick enough to treat safely; and no active infection or central scarring that would compromise the result. The keratoconus evaluation establishes each of these, and our team helps with insurance paperwork where needed before scheduling.

Is this right for your eyes?

Nothing on this page is a diagnosis. Whether this is the right choice for you is decided by a full examination at one of our 4 offices: Pasadena, Huntington Beach, Woodland Hills and Beverly Hills.

About this content: This page was written with the assistance of AI tools and reviewed for medical accuracy by Dr. Bavand Youssefzadeh, DO. It is general information, not medical advice, and does not replace an eye examination. Individual results vary. Read our medical disclaimer.

Related pages

Corneal topography measured during a keratoconus evaluationModel

Frequently Asked Questions

The FDA approved procedure for progressive keratoconus is often covered by medical insurance, usually with prior authorization; our team checks your coverage and helps with insurance paperwork where needed. Coverage for unapproved variants is uncommon.

Essentially, yes. The epithelium-off protocol originated in Germany in the early 2000s, and the FDA approval standardized it for the United States with its own trial data.

Yes. The approval covers patients 14 and older, and teenagers are the group who benefit most because they progress fastest.

What patients say about us

Model

Ready To See Clearly?

Your consultation is free, by video or in person. You leave with a personal plan, a written quote and 0% financing options.

Contact Us

We encourage you to contact us with any questions or comments you may have. Call us at (855) 456-2253 or use the quick contact form below.